PETX
Aratana Therapeutics, Inc.
PETX
PETX
Delisted
PETX was delisted on the 17th of July, 2019.
96 hedge funds and large institutions have $194M invested in Aratana Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 40 increasing their positions, 15 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
14% less capital invested
Capital invested by funds: $227M → $194M (-$32.4M)
57% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 14
Holders
96
Holding in Top 10
2
Calls
$386K
Puts
$44K
Top Buyers
| 1 | +$1.53M | |
| 2 | +$727K | |
| 3 | +$650K | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$563K |
| 5 |
Renaissance Technologies
New York
|
+$492K |
Top Sellers
| 1 | -$1.13M | |
| 2 | -$1.09M | |
| 3 | -$723K | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
-$549K |
| 5 |
3C
361 Capital
Denver,
Colorado
|
-$405K |